How Will the Hepatitis Therapeutics Market Grow Over the Forecast Period Based on Its Expected CAGR?
The market size of hepatitis therapeutics has been on a consistent growth trajectory in the past few years. The market value, which stands at $18.66 billion in 2024, is projected to expand to $19.27 billion in 2025, recording a compound annual growth rate (CAGR) of 3.2%. Factors such as the development of vaccines, antiviral medications, public health efforts, funding for research, and the advent of new therapy modalities are responsible for the growth experienced in the historic period.

A consistent increase in the size of the hepatitis therapeutics market is anticipated in the coming years, growing to a robust $22.75 billion by 2029 with a compound annual growth rate (CAGR) of 4.2%. The predicted growth during the forecast period is the result of ongoing research and development, worldwide health initiatives, shifts in patient care, government strategies, and increased awareness of the disease. Major trends expected during the forecast period feature patient advocacy and support, continual observation and follow-up, health care equality, telemedicine and remote care, and a concentrated effort to eliminate Hepatitis C.

Which Macro and Microeconomic Factors Are Accelerating the Growth of the hepatitis therapeutics Market?
The global increase in hepatitis infections is anticipated to drive the growth of the hepatitis therapeutic market. Factors such as insufficient access to healthcare and vaccinations, escalation in intravenous drug use, unsafe practices of blood transfusion, as well as poor conditions of sanitation and hygiene in certain global regions are the causes of this increase in hepatitis infections. For example, in April 2022, from 11 countries, the World Health Organization (WHO), a United Nations public health entity based in the United States, recorded at least 169 cases of acute hepatitis of unknown cause and revealed that there are 350 million individuals across the globe suffering from viral hepatitis B or C. However, most of these individuals still lack access to testing and treatment. Consequently, the increasing hepatitis infection rate is causing expansion in the market for hepatitis therapeutics.

Request Your Free Hepatitis Therapeutics Market Report Sample Now!
https://www.thebusinessresearchcompany.com/sample.aspx?id=9956&type=smp

Who Are the Key Firms Paving the Way for Growth in the Hepatitis Therapeutics Market?
Major companies operating in the hepatitis therapeutics market include:
• Gilead Sciences Inc.
• Bristol-Myers Squibb Co.
• AbbVie Inc.
• Merck & Co. Inc.
• Johnson & Johnson Services Inc.

What Are the Most Influential Trends Currently Shaping the Hepatitis Therapeutics Market?
The rise in product innovations is an important trend being noticed in the hepatitis therapeutics market. Major players in this market are focusing on developing new products to maintain their stronghold. Take for instance Gilead Sciences, Inc., a biopharmaceutical organization based in the US. They garnered FDA approval in November 2022 for their medicine, Vemlidy (tenofovir alafenamide), used for treating pediatric patients suffering from chronic hepatitis B virus infection. Vemlidy, which was initially given FDA approval in 2016, is a targeted prodrug of tenofovir and is a daily treatment for people suffering from chronic hepatitis B virus infection and compensated liver disease. As per the American Liver Foundation’s advice, this drug is the recommended first-line treatment for individuals with chronic HBV and compensated liver conditions.

Pre-order Your Report for Quick and Easy Delivery!
https://www.thebusinessresearchcompany.com/report/hepatitis-therapeutics-global-market-report

How Are Market Segments in the Hepatitis Therapeutics Industry Positioned for Long-Term Growth?
The hepatitis therapeutics market covered in this report is segmented –

1) By Disease Type: Hepatitis A, Hepatitis B, Hepatitis C, Other Disease Types
2) By Drug Class: Oral Antivirals, Immune Modulators
3) By Distribution Channel: Hospital Pharmacies, Drug Stores And Retail Pharmacies, Online Providers

Subsegments:
1) By Hepatitis A: Vaccines, Post-Exposure Prophylaxis (PEP)
2) By Hepatitis B: Antiviral Medications, Immune Modulators, Vaccines
3) By Hepatitis C: Direct-Acting Antivirals (DAAs), Ribavirin, Interferon-Based Therapies
4) By Other Disease Types: Hepatitis D, Hepatitis E, Other Viral Hepatitis Infections

Which Regions Are Essential for the Growth of the Hepatitis Therapeutics Market?
North America was the largest region in the hepatitis therapeutics market in 2024. Asia-Pacific is expected to be the fastest-growing region in the hepatitis therapeutics market report during the forecast period. The regions covered in the hepatitis therapeutics market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

How Is the Scope and Reach of the Hepatitis Therapeutics Market Defined?
Hepatitis is an inflammation of the liver caused by several viruses and non-viruses. The term hepatitis therapeutics describes the drugs that are used to treat all forms of hepatitis. The two drugs used to treat hepatitis are immune modulators and oral antivirals.

Browse Through More Similar Reports By The Business Research Company:

Healthcare/Medical Simulation Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/healthcare-medical-simulation-global-market-report

Healthcare BPO Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/healthcare-bpo-global-market-report

Healthcare Services Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/healthcare-service-global-market-report

About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at [email protected]

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Found this article helpful? Share it on: